526445 — Indrayani Biotech Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMicro CapContrarian

Annual income statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	616	1,629	1,662	1,302	1,378
Cost of Revenue
Gross Profit	202	607	624	420	438
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	555	1,496	1,464	1,272	1,325
Operating Profit	61.2	134	199	30.1	53.3
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	44.6	123	110	-57.4	3
Provision for Income Taxes
Net Income After Taxes	44.6	119	104	-61.1	21.6
Net Income Before Extraordinary Items
Net Income	44.6	119	104	-61.1	21.6
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	44.4	119	104	-61.1	21.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.3	2.86	2.68	-1.34	0.48